Showing results (221-230 of 253) with videos related to

Sort By:
Pageof 26
The Journal of Antimicrobial Chemotherapy|June 9, 2022
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosisKamunkhwala Gausi, Maxwell Chirehwa, Elisa H Ignatius, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|October 9, 2023
Objectively measured medication adherence using assays for carvedilol and enalaprilat in patients with heart failure in Mozambique and NigeriaJulius Chacha Mwita, Andre Joubert, Hadiza Saidu, et al.
The Journal of Antimicrobial Chemotherapy|July 10, 2024
The impact of alcohol and illicit substance use on the pharmacokinetics of first-line TB drugsMarie Wijk, Kamunkhwala Gausi, Samantha Malatesta, et al.
Plos One|May 13, 2024
A study protocol to characterise pathophysiological and molecular markers of rheumatic heart disease and degenerative aortic stenosis using multiparametric cardiovascular imaging and multiomics techniquesDaniel W Mutithu, Olukayode O Aremu, Dipolelo Mokaila, et al.
Malaria Journal|January 7, 2021
Pharmacokinetic profile of amodiaquine and its active metabolite desethylamodiaquine in Ghanaian patients with uncomplicated falciparum malariaThomas A Anyorigiya, Sandra Castel, Katya Mauff, et al.
The Lancet. HIV|June 17, 2019
Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trialWillem D F Venter, Michelle Moorhouse, Simiso Sokhela, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 22, 2021
Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization-Recommended Weight Band Doses and FormulationsChishala Chabala, Anna Turkova, Anneke C Hesseling, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2021
Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant WomenJyoti S Mathad, Rada Savic, Paula Britto, et al.
The Journal of Infectious Diseases|October 30, 2025
Pharmacokinetics and Safety of Clofazimine in Women With Rifampicin-resistant Tuberculosis During Pregnancy and the Postpartum Period: Results From IMPAACT P1026sJennifer A Hughes, Flynn McMorrow, Kristina M Brooks, et al.
The Pediatric Infectious Disease Journal|January 19, 2021
Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092Maxensia Owor, Camlin Tierney, Lauren Ziemba, et al.
Pageof 26